학술논문
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study
Document Type
Article
Author
Hurvitz, Sara A ; Bardia, Aditya; Quiroga, Vanesa; Park, Yeon Hee; Blancas, Isabel; Alonso-Romero, José Luis; Vasiliev, Aleksandr; Adamchuk, Hryhoriy; Salgado, Marcelo; Yardley, Denise A; Berzoy, Oleksandr; Zamora-Auñón, Pilar; Chan, David; Spera, Gonzalo; Xue, Cloris; Ferreira, Erika; Badovinac Crnjevic, Tanja; Pérez-Moreno, Pablo Diego; López-Valverde, Vanesa; Steinseifer, Jutta; Fernando, Tharu M; Moore, Heather M; Fasching, Peter A
Source
In The Lancet Oncology September 2023 24(9):1029-1041
Subject
Language
ISSN
1470-2045